Peptide Therapy · Physician-Directed

Peptide Therapy,
Prescribed From Labs

Peptides are the native vocabulary your cells already speak — short amino-acid sequences that say specific sentences: repair this tendon, deepen this sleep, burn this fat. The internet sells them as a menu. We prescribe them as medicine: selected from your lab work, cycled with intent, and re-measured.

The Signal Library

Matched to the bottleneck, not the trend.

i.Repair & recovery BPC-157, TB-500, Thymosin β-4 — run alongside orthobiologic procedures to extend and consolidate the repair window.

ii.Metabolic & growth CJC-1295, Ipamorelin, Semaglutide, Tirzepatide — dismantling the insulin resistance that keeps tissue inflamed.

iii.Longevity & cognition MOTS-c, SS-31, Epitalon, Dihexa, Selank — mitochondrial efficiency, immune recalibration, cognitive clarity.

iv.Sleep, skin, vitality DSIP for the deep-sleep architecture repair requires; GHK-Cu for collagen signaling; PT-141 for libido’s neurological driver.

Every protocol begins with the metabolic panel and ends with a re-measure. No labs, no peptides — that is the filter, and it is why our protocols work. Full catalog in Pillar III — The Signal Library.

Request Clinical Evaluation Review Pillar III

Peptides are selected from lab data — never from a menu

What A Peptide Actually Is

Short signals, not a shortcut

A peptide is a short chain of amino acids — the same building blocks proteins are made from, assembled into a sequence brief enough to act as a message rather than a structure. Insulin is a peptide. So is parathyroid hormone. The body uses them constantly to tell tissues what to do.

That is the reasonable case for using them therapeutically, and it is also where the honest account has to become more careful. A molecule being naturally occurring says nothing about whether a particular sequence, at a particular dose, produces a particular clinical result in humans. Those are separate questions and they are answered by evidence, not by the fact that the body makes something similar.

Regulatory Status

Which of these are approved drugs, and which are not

This distinction is rarely made plainly on clinic websites, and patients deserve it before deciding anything.

i.FDA-approved medications Semaglutide [the GLP-1 agonist sold as Ozempic and Wegovy] and tirzepatide [the dual agonist sold as Mounjaro and Zepbound] are approved drugs with large trial programs behind them. When these are prescribed here, they are prescribed as the medications they are.

ii.Compounded preparations Several peptides are available through compounding pharmacies under specific regulatory pathways. Availability is not equivalent to approval, and the pathway itself is under active review.

iii.Research compounds A number of peptides discussed widely online are sold only for laboratory research and are not approved for human use. We do not prescribe from that category.

In July 2026 the FDA’s Pharmacy Compounding Advisory Committee convened on the eligibility of several peptide compounds, and the regulatory picture continues to move. Our reading of what that means for patients is set out in our note on the reclassification. The short version is that a shifting framework makes physician oversight and laboratory-guided prescribing more important, not less.

How Selection Works

From the panel, not from the menu

Peptides are chosen here to address a bottleneck that was measured, which means the sequence is the last decision rather than the first. A patient who arrives asking for a specific compound is asked what problem it is meant to solve, and then whether that problem has been demonstrated on their own labs.

Repair and recovery

Used alongside orthobiologic procedures to support the repair window rather than as standalone treatment. The evidence base here is largely preclinical, and we say so.

Metabolic and growth axis

Where insulin resistance is the demonstrated bottleneck, this is the category with by far the strongest human evidence, and it overlaps directly with metabolic optimization.

Sleep, cognition and vitality

Considered where a specific deficit has been identified and other causes have been examined first. Sleep in particular is frequently a structural or behavioral problem rather than a signaling one, and treating it as the latter when it is the former wastes a year.

Boundaries

What we will not do

We do not dispense from a menu, prescribe without laboratory work, supply compounds sold for research use only, or continue a protocol that has not produced a measurable change. We also do not present peptides as an alternative to correcting nutrition, sleep and activity — a signal cannot compensate for absent substrate.

Results vary, and some patients get little from a given protocol. That is why the re-measure is scheduled at the outset rather than offered if you ask.

Common Questions

Questions worth asking any peptide prescriber

Are peptides covered by insurance?

Approved medications sometimes are, subject to the plan’s criteria. Compounded preparations generally are not. You are told the category and the cost basis before anything is ordered.

How long does a protocol run?

Most are cycled over defined periods with a re-measure at the end rather than continued indefinitely. Clinical need decides duration, not a subscription.

Can I bring my own compound?

No. We cannot verify the identity, purity or dosing of material obtained elsewhere, and prescribing around an unverified substance is not something a physician can do responsibly.

Is this the same as hormone replacement?

No. Some peptides act on the growth axis, but hormone restoration is a separate assessment with its own monitoring, handled within the metabolic program.

Peptide Therapy,Prescribed From Labs